Andrea M. Zuhl
AstraZeneca (United States)(US)
Publications by Year
Research Areas
Peptidase Inhibition and Analysis, Catalytic C–H Functionalization Methods, Click Chemistry and Applications, N-Heterocyclic Carbenes in Organic and Inorganic Chemistry, Protein Degradation and Inhibitors
Most-Cited Works
- → NNMT promotes epigenetic remodeling in cancer by creating a metabolic methylation sink(2013)434 cited
- → Direct Nucleophilic Acylation of Nitroalkenes Promoted by a Fluoride Anion/Thiourea Combination(2006)151 cited
- → Thiazolium-Catalyzed Additions of Acylsilanes: A General Strategy for Acyl Anion Addition Reactions(2006)143 cited
- → Total Synthesis of (+)-Fendleridine (Aspidoalbidine) and (+)-1-Acetylaspidoalbidine(2010)119 cited
- → Chemoproteomic profiling reveals that cathepsin D off-target activity drives ocular toxicity of β-secretase inhibitors(2016)76 cited
- → Discovery and Optimization of Sulfonyl Acrylonitriles as Selective, Covalent Inhibitors of Protein Phosphatase Methylesterase-1(2011)71 cited
- → Competitive Activity-Based Protein Profiling Identifies Aza-β-Lactams as a Versatile Chemotype for Serine Hydrolase Inhibition(2012)61 cited
- → Selective Inhibitor of Platelet-Activating Factor Acetylhydrolases 1b2 and 1b3 That Impairs Cancer Cell Survival(2015)52 cited
- → Axl receptor tyrosine kinase is a regulator of apolipoprotein E(2020)25 cited
- → The Vital Role of Proteomics in Characterizing Novel Protein Degraders(2021)20 cited